Aarti Pharmalabs informs about disclosure

01 Apr 2025 Evaluate

Pursuant to Regulation 30 read with Schedule III to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Aarti Pharmalabs has informed that the Company (‘APL’) has executed an Addendum to the Subscription and Shareholders Agreement entered into between the Company and the Hemant Bandodkar & family (Bandodkars) pursuant to which Ganesh Polychem (GPL) would be Joint Venture Company of APL with effect from the close of business hours of 31st March 2025. The details as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. SEBI/HO/CFD/CFDPoD-1/P/CIR/2023/123 dated July 13, 2023, is given in Annexure 'A' attached to this letter.

The above information is a part of company’s filings submitted to BSE.

Aarti Pharmalabs Share Price

722.05 -0.95 (-0.13%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×